STARVATION KETOACIDOSIS

STARVATION KETOACIDOSIS was reported 202 times

These drug classes are most commonly taken by patients reporting STARVATION KETOACIDOSIS:

# Drug Count
0 GLP-1 Receptor Agonist [EPC] 80
1 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 59
2 Nonsteroidal Anti-inflammatory Drug [EPC] 38
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 36
4 Atypical Antipsychotic [EPC] 19
5 Proton Pump Inhibitor [EPC] 19
6 Insulin Analog [EPC] 17
7 Benzodiazepine [EPC] 16
8 Corticosteroid [EPC] 13
9 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 9
10 Serotonin-3 Receptor Antagonist [EPC] 9
11 Angiotensin 2 Receptor Blocker [EPC] 8
12 Peroxisome Proliferator Receptor alpha Agonist [EPC] 8
13 Phenothiazine [EPC] 8
14 HMG-CoA Reductase Inhibitor [EPC] 7
15 Factor Xa Inhibitor [EPC] 6
16 Osmotic Laxative [EPC] 6
17 Platelet Aggregation Inhibitor [EPC] 5
18 Provitamin D2 Compound [EPC] 5
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4
20 Macrolide Antimicrobial [EPC] 4
21 Macrolide [EPC] 4
22 Programmed Death Receptor-1 Blocking Antibody [EPC] 4
23 Alkaloid [EPC] 3
24 Antidote [EPC] 3
25 Calcium Channel Blocker [EPC] 3
26 Dihydropyridine Calcium Channel Blocker [EPC] 3
27 General Anesthetic [EPC] 3
28 Glycopeptide Antibacterial [EPC] 3
29 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
30 Microtubule Inhibitor [EPC] 3
31 Opioid Agonist [EPC] 3
32 Vitamin B12 [EPC] 3
33 Vitamin C [EPC] 3
34 alpha-Adrenergic Blocker [EPC] 3
35 beta-Adrenergic Blocker [EPC] 3
36 Angiotensin Converting Enzyme Inhibitor [EPC] 2
37 Aromatic Amino Acid [EPC] 2
38 Dietary Cholesterol Absorption Inhibitor [EPC] 2
39 Serotonin Reuptake Inhibitor [EPC] 2
40 Sulfonylurea [EPC] 2
41 Tetracycline-class Drug [EPC] 2
42 Vitamin D [EPC] 2
43 Alkylating Drug [EPC] 1
44 Aluminum Complex [EPC] 1
45 Antihypoglycemic Agent [EPC] 1
46 Antisense Oligonucleotide [EPC] 1
47 Azole Antifungal [EPC] 1
48 Bismuth [EPC] 1
49 CD19-directed Chimeric Antigen Receptor [EPC] 1
50 CD20-directed Cytolytic Antibody [EPC] 1
51 Central alpha-2 Adrenergic Agonist [EPC] 1
52 Copper-containing Intrauterine Device [EPC] 1
53 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
54 Estrogen Receptor Antagonist [EPC] 1
55 Expectorant [EPC] 1
56 Gastrointestinal Motility Inhibitor [EPC] 1
57 Genetically-modified Autologous T Cells [EPC] 1
58 Histamine-2 Receptor Antagonist [EPC] 1
59 Insulin [EPC] 1
60 Integrin Receptor Antagonist [EPC] 1
61 Interleukin-23 Antagonist [EPC] 1
62 Interleukin-6 Receptor Antagonist [EPC] 1
63 Janus Kinase Inhibitor [EPC] 1
64 Kinase Inhibitor [EPC] 1
65 Loop Diuretic [EPC] 1
66 P2Y12 Platelet Inhibitor [EPC] 1
67 Partial Opioid Agonist [EPC] 1
68 Peroxisome Proliferator Receptor gamma Agonist [EPC] 1
69 Phosphodiesterase 5 Inhibitor [EPC] 1
70 Potassium Salt [EPC] 1
71 Purine Antimetabolite [EPC] 1
72 Recombinant Human Growth Hormone [EPC] 1
73 Sigma-1 Agonist [EPC] 1
74 Sodium Channel Blocker [EPC] 1
75 Standardized Chemical Allergen [EPC] 1
76 Stimulant Laxative [EPC] 1
77 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
78 Thiazide-like Diuretic [EPC] 1
79 Thiazolidinedione [EPC] 1
80 Tumor Necrosis Factor Blocker [EPC] 1
81 Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] 1